Colonial Trust Advisors Amgen Inc Transaction History

Colonial Trust Advisors

$1.04 Billion
Q2 2024

A detailed history of Colonial Trust Advisors transactions in Amgen Inc stock. As of the latest transaction made, Colonial Trust Advisors holds 1,945 shares of AMGN stock, worth $614,620. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,945

Previous 1,982 1.87%

Holding current value

$614,620

Previous $563,000 7.82%

% of portfolio

0.06%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $9,721 - $11,814	-37 Reduced 1.87%	1,945 $607,000
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $13,443 - $16,228	50 Added 2.59%	1,982 $563,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $307,607 - $347,017	-1,203 Reduced 38.37%	1,932 $556,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $11,588 - $14,387	-53 Reduced 1.66%	3,135 $842,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $428 - $506	2 Added 0.06%	3,188 $707,000
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $1,128 - $1,376	-5 Reduced 0.16%	3,186 $770,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $23,132 - $29,392	-101 Reduced 3.07%	3,191 $838,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $238,376 - $268,845	1,062 Added 47.62%	3,292 $742,000
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $3,069 - $3,395	14 Added 0.63%	2,230 $539,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $19,888 - $22,760	100 Added 4.73%	2,216 $499,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $5,306 - $6,217	25 Added 1.2%	2,116 $450,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $9,098 - $10,602	41 Added 2.0%	2,091 $520,000
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $10,819 - $12,883	-50 Reduced 2.38%	2,050 $471,000
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $104,888 - $116,644	447 Added 27.04%	2,100 $534,000
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $2,571 - $3,155	13 Added 0.79%	1,653 $390,000
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $72,896 - $96,680	-400 Reduced 19.61%	1,640 $332,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $56,763 - $72,960	300 Added 17.24%	2,040 $492,000
Q3 2019 Nov 15, 2019	SELL	$174.11 - $208.62 $54,148 - $64,880	-311 Reduced 15.16%	1,740 $337,000
Q2 2019 Aug 21, 2019	BUY	$166.7 - $195.41 $51,843 - $60,772	311 Added 17.87%	2,051 $378,000
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $45,217 - $50,970	-250 Reduced 12.56%	1,740 $331,000
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $8,920 - $10,412	-50 Reduced 2.45%	1,990 $387,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $49,815 - $55,953	300 Added 17.24%	2,040 $377,000
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $63,366 - $74,052	-374 Reduced 17.69%	1,740 $297,000
Q4 2017 Feb 21, 2018	BUY	$168.79 - $188.59 $63,127 - $70,532	374 Added 21.49%	2,114 $368,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,740	1,740 $300,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.

Account

Colonial Trust Advisors Amgen Inc Transaction History